Tumor cell-derived IL-1α has been linked with higher metastasis in lung cancer and breast cancer, indicating potential therapeutic value for blocking the IL-1α/IL1R/MyD88/TET2 axis (65, 66). This evidence concerns the gene IL1A and lung cancer.